Clicky

OPTIBIOTIX HLTH PLC LS-02(OB3)

Description: OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulators in the United Kingdom, the United States, China, and internationally. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology and derive potential health benefits. Its products include Slimbiome, which offers a healthy and hunger-free weight management system; SlimBiome Medical, a natural supplement for weight management; Lactobacillus plantarum LPLDL, a probiotic that aids elements of cardiovascular and wellbeing; CholBiome, a food supplement for reducing cholesterol and blood pressure; LPGOS, a galactooligosaccharide that is used in food products and applications, which helps reduce cardiovascular risk factors and enhance health; and Sweetbiotix, a low calorie sweetener for food and beverages. The company's products prevent and manage chronic lifestyle disorders, including obesity, hypercholesterolemia, and diabetes. The company was formerly known as Ducat Ventures PLC and changed its name to OptiBiotix Health Plc in August 2014. OptiBiotix Health Plc was incorporated in 2006 and is headquartered in York, the United Kingdom.


Keywords: Food Products Diabetes Nutrition Food Ingredients Obesity Digestive System Cholesterol Weight Management Hypercholesterolemia Probiotics Gram Positive Bacteria Food Supplement Lactobacillaceae Lactobacillus Microbial Strains

Home Page: optibiotix.com

Innovation Centre
York, YO10 5DG
United Kingdom
Phone:


Officers

Name Title
Mr. Stephen Patrick O'Hara Founder, CEO & Executive Director
Dr. Sofia Kolyda Executive Director of Research & Development and Executive Director
Mr. David Jonathan Blain ACA Acting Finance Director
Paul Cannings Head of Operations & Quality
Kevin James Newman Corporate Development Director
Mr. Karl Burkitt Marketing Director
Mr. Mark Kingsley Collingbourne Secretary

Exchange: F

Country: DE : Germany

Currency: Euro (€)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 2.5377
Price-to-Sales TTM: 40.5532
IPO Date:
Fiscal Year End: December
Full Time Employees: 10
Back to stocks